Related Experiment Video
Updated: Jul 16, 2026

Functional Transcranial Doppler Ultrasound for Monitoring Cerebral Blood Flow
Published on: March 15, 2021
Transcranial Doppler findings in patients with COVID-19: a prospective observational study
Marcella Barreto Santos1, Ana Flávia Silveira2, João Brainer Clares de Andrade1,3
1Universidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.
Insights
This study found no microembolic signals (MESs) in COVID-19 patients using Transcranial Doppler (TCD). However, elevated inflammatory markers like C-reactive protein (CRP) and D-dimer were linked to lower estimated cerebral perfusion pressure (eCPP).
Area of Science:
- Neuroscience
- Critical Care Medicine
- Infectious Diseases
Background:
- Transcranial Doppler (TCD) detects microembolic signals (MESs) in intracranial circulation.
- Critically-ill COVID-19 patients may have increased MESs due to inflammation and hypercoagulability.
Purpose of the Study:
- To assess MESs and TCD parameters (cerebral blood flow velocity, pulsatility, resistance indices) in COVID-19 patients.
- To calculate estimated cerebral perfusion pressure (eCPP) in patients with and without COVID-19.
Main Methods:
- One-hour TCD monitoring in middle cerebral arteries (MCAs) of ICU patients with confirmed COVID-19.
- Calculation of eCPP using mean arterial pressure (MAP) and CBFV parameters.
- Comparison of TCD parameters and eCPP between COVID-19 and non-COVID-19 groups.
Main Results:
- No MESs were detected in any patient group.
- A positive correlation was observed between MCA resistance index and D-dimer.
- Negative correlations were found between direct bilirubin, CRP, aPTT, D-dimer, and eCPP.
Conclusions:
- No spontaneous cerebral microemboli were observed in this cohort.
- Higher levels of direct bilirubin, CRP, aPTT, and D-dimer were associated with lower eCPP in patients.
Background:
Transcranial Doppler (TCD) is a diagnostic tool to detect real-time spontaneous microembolic signals (MESs) in intracranial circulation. Critically-ill coronavirus disease 2019 (COVID-19) patients may present an increased likelihood of MESs due to systemic inflammation and hypercoagulability.
Objective:
To assess the presence of MESs and other TCD parameters, including cerebral blood flow velocity (CBFV), pulsatility, and resistance indices, and to calculate the estimated cerebral perfusion pressure (eCPP) in patients with and without COVID-19.
Methods:
The TCD monitoring was performed for 1 hour in both middle cerebral arteries (MCAs) of adult patients in the Intensive Care Unit (ICU) with confirmed COVID-19 infection. The eCPP was calculated by multiplying the mean arterial pressure (MAP) by the ratio of end-diastolic velocity to mean CBFV, then adding 14 mmHg.
Results:
We evaluated 31 subjects: 11 intubated COVID-19 patients, 10 non-intubated COVID-19 patients, and 10 intubated non-COVID-19 patients. Patient ages ranged from 29 to 84 (median: 62; interquartile range [IQR]: 50-70) years, with 64.5% being male individuals. A total of 17 (54.8%) subjects died during hospitalization, and 2 patients (6.45%) lacked an ultrasonographic signal via the transtemporal window. No MESs were detected. A positive correlation was found between the resistance index of MCAs (p = 0.390) and D-dimer (p = 0.049). In contrast, direct bilirubin (p = -0.494), C-reactive protein (CRP; p = -0.540), activated partial thromboplastin time (aPTT; p = -0.495), and D-dimer (p = -0.439) were negatively correlated with eCPP.
Conclusion:
No spontaneous cerebral microemboli were observed in this cohort, but patients with higher direct bilirubin, CRP, aPTT, and D-dimer presented lower eCPP.
Related Concept Videos
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Increased Intracranial Pressure ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

